National Research (NRC) Stock Price, News & Analysis

Company Overview

National Research Corporation (NASDAQ: NRC) is a healthcare analytics and performance improvement company founded in 1964. Headquartered in Lincoln, Nebraska, the company has built a reputation for delivering rigorous patient experience measurement and market research solutions. Over its history, National Research has evolved from a regional survey provider into a full‐service analytics partner for healthcare organizations seeking to enhance quality, safety and patient satisfaction.

The company’s core offerings span patient experience surveys, employee engagement assessments and safety culture evaluations. Utilizing proprietary data collection methodologies and advanced analytics, National Research helps hospitals, health systems and post‐acute care providers identify improvement opportunities and benchmark performance. The firm also offers real‐time reporting platforms and consultative services designed to translate survey results into actionable strategies for care delivery teams.

National Research serves a broad network of clients across North America, including acute care hospitals, physician practices, home health agencies and long‐term care facilities. Its solutions are tailored to meet the needs of organizations of varying sizes, from large health systems to community clinics. By integrating feedback from patients, family members and staff, the company enables providers to align with regulatory requirements, payer expectations and patient‐centered care initiatives.

Under the leadership of President and Chief Executive Officer Michael Timberman, National Research continues to expand its data capabilities and client offerings. The executive team combines expertise in healthcare operations, technology and research methodology to foster continuous innovation. As the industry shifts toward value‐based care and digital engagement, National Research is positioned to support providers in improving outcomes, enhancing experiences and demonstrating measurable value.

Key Stats

• Today's Range: $14.19 to $15.04
• 50-Day Range: $13.30 to $17.24
• 52-Week Range: $9.76 to $27.07
• Volume: 77,099 shs
• Average Volume: 89,820 shs
• Market Capitalization: $323.93 million
• P/E Ratio: 13.81
• Dividend Yield: 3.38%
• Price Target: N/A
• Consensus Rating: N/A

National Research Stock Analysis - MarketRank™

National Research scored higher than 44% of companies evaluated by MarketBeat, and ranked 194th out of 312 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for National Research.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of National Research is 13.81, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.98.

Price to Earnings Ratio vs. Sector

The P/E ratio of National Research is 13.81, which means that it is trading at a less expensive P/E ratio than the Business Services sector average P/E ratio of about 24.70.

Price to Book Value per Share Ratio

National Research has a P/B Ratio of 10.46. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.74% of the float of National Research has been sold short.

Short Interest Ratio / Days to Cover

National Research has a short interest ratio ("days to cover") of 4.8.

Change versus previous month

Short interest in National Research has recently decreased by 5.58%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

National Research pays a meaningful dividend of 3.21%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

National Research does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of National Research is 46.60%. This payout ratio is at a healthy, sustainable level, below 75%.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

3.74% of the float of National Research has been sold short.

Short Interest Ratio / Days to Cover

National Research has a short interest ratio ("days to cover") of 4.8.

Change versus previous month

Short interest in National Research has recently decreased by 5.58%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 1.3 / 5
• News Sentiment: N/A

News Sentiment

National Research has a news sentiment score of 0.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.91 average news sentiment score of Business Services companies.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, National Research insiders have bought more of their company's stock than they have sold. Specifically, they have bought $33,975.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

Only 8.10% of the stock of National Research is held by insiders.

Percentage Held by Institutions

47.26% of the stock of National Research is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

NRC Stock Analysis - Frequently Asked Questions

How have NRC shares performed this year?

National Research's stock was trading at $17.64 at the beginning of 2025. Since then, NRC stock has decreased by 19.4% and is now trading at $14.22.

How were National Research's earnings last quarter?

National Research Corporation (NASDAQ:NRC) issued its earnings results on Monday, April, 28th. The company reported $0.25 earnings per share for the quarter. The company had revenue of $33.55 million for the quarter. National Research had a net margin of 17.14% and a trailing twelve-month return on equity of 71.33%.

Does National Research have any subsidiaries?

National Research subsidiaries include PatientWisdom Inc., The Governance Institute, and National Research Corporation Canada.

Who are National Research's major shareholders?

Top institutional investors of National Research include Significant Wealth Partners LLC (0.06%) and Signaturefd LLC (0.02%). Insiders that own company stock include Amandla Mk Trust, Patrick E Beans, Kevin R Karas and Jona S Raasch.
View institutional ownership trends.

How do I buy shares of National Research?

Shares of NRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of National Research own?

Based on aggregate information from My MarketBeat watchlists, some other companies that National Research investors own include Meta Platforms (META), NVIDIA (NVDA), Tesla (TSLA), Alphabet (GOOG), Netflix (NFLX), Advanced Micro Devices (AMD) and JPMorgan Chase & Co. (JPM).

Company Calendar

• Last Earnings: 4/28/2025
• Record date for 7/11 Dividend: 6/27/2025
• Ex-Dividend for 7/11 Dividend: 6/27/2025
• Dividend Payable: 7/11/2025
• Today: 7/18/2025
• Next Earnings (Estimated): 7/28/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: BUSINESS INFO SVC
• Sub-Industry: Business Services
• Current Symbol: NASDAQ:NRC
• CIK: 70487
• Web: www.nrchealth.com
• Phone: (402) 475-2525
• Fax: 402-475-9061
• Employees: 490
• Year Founded: 1981

Profitability

• EPS (Trailing Twelve Months): $1.03
• Trailing P/E Ratio: 13.81
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $24.78 million
• Net Margins: 17.14%
• Pretax Margin: 22.80%
• Return on Equity: 71.33%
• Return on Assets: 18.67%

Debt

• Debt-to-Equity Ratio: 1.98
• Current Ratio: 0.54
• Quick Ratio: 0.54

Sales & Book Value

• Annual Sales: $143.06 million
• Price / Sales: 2.26
• Cash Flow: $1.27 per share
• Price / Cash Flow: 11.20
• Book Value: $1.36 per share
• Price / Book: 10.46

Miscellaneous

• Outstanding Shares: 22,780,000
• Free Float: 20,939,000
• Market Cap: $323.93 million
• Optionable: Optionable
• Beta: 0.45